Established in 2017, Fubio (Suzhou) Biotechnology Co., Ltd. is a specialized platform company dedicated to gene delivery vector research and clinical translation. We pride ourselves on providing clients with seamless, end-to-end viral product and service solutions, guiding them from initial basic research through to clinical implementation.

We operate China's most diverse and extensive viral vector library, encompassing a wide range of types such as Lentivirus, Adenovirus, Adeno-associated virus (AAV), and Oncolytic Virus. Our collaborations extend to over 500 institutions across various sectors, including life sciences, in vitro diagnostics (IVD), vaccine development, and cutting-edge cell and gene therapy (CGT). By supporting both academic and industrial clients, we aim to advance their research and expedite the development of transformative clinical products.